Charles River Laboratories
230 hedge funds and large institutions have $2.17B invested in Charles River Laboratories in 2013 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 98 increasing their positions, 79 reducing their positions, and 19 closing their positions.
840% more call options, than puts
Call options by funds: $28.3M | Put options by funds: $3.01M
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
24% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 79
12% more capital invested
Capital invested by funds: $1.93B → $2.17B (+$233M)
2% more funds holding
Funds holding: 225 → 230 (+5)
0.63% less ownership
Funds ownership: 96.05% → 95.43% (-0.63%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$17.1M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$13.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$9.32M |
| 4 |
Millennium Management
New York
|
+$8.36M |
| 5 |
D.E. Shaw & Co
New York
|
+$7.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$25.9M |
| 2 |
KeyBank National Association
Cleveland,
Ohio
|
-$23.4M |
| 3 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
-$23M |
| 4 |
Bank of New York Mellon
New York
|
-$20.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$16.7M |
CRL Hedge Fund Activity: Q3 2013 in Review
230 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q3 2013, worth a combined $2.17B — up 12% from $1.93B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new CRL positions and 19 closed out — a net gain of 9 holders — while 98 added to existing stakes and 79 trimmed.
The largest buyer was Eaton Vance Management, opening a new position worth an estimated $17.1M. The largest seller was Deutsche Bank, cutting an estimated $25.9M.
- 230 institutional investors held Charles River Laboratories (CRL) as of Q3 2013, up from 225 in Q2 2013.
- Funds reported $2.17B of Charles River Laboratories stock for Q3 2013, up 12% quarter-over-quarter.
- 28 funds opened new Charles River Laboratories positions in Q3 2013 and 19 closed out, a net change of +9 holders.
- The largest Charles River Laboratories buyer in Q3 2013 was Eaton Vance Management, an estimated $17.1M added.
- The largest Charles River Laboratories seller in Q3 2013 was Deutsche Bank, an estimated $25.9M sold.
Based on aggregated 13F filings for Q3 2013.